MedTrace Logo

COVID SAFE: COVID-19 Screening Assessment for Exposure

NCT04508777 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1759

Last updated 2022-03-02

No results posted yet for this study

Summary

In order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage their spread while balancing program effectiveness, feasibility, costs, and scalability.

This study will evaluate the implementation of a COVID-19 screening program that coordinates several existing systems at the University of Pennsylvania including saliva-based viral testing.

Conditions

  • Covid19

Interventions

BEHAVIORAL

Saliva-based testing

Participants will take part in a voluntary COVID-19 screening program that includes bi-weekly saliva-based testing.

Sponsors & Collaborators

Principal Investigators

  • Mitesh S Patel, MD · University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-09
Primary Completion
2020-12-08
Completion
2021-06-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04508777 on ClinicalTrials.gov